Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'GDEPT' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 22 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Djeha, AH; Thomson, TA; Leung, H; Searle, PF; Young, LS; Kerr, DJ; Harris, PA; Mountain, A; Wrighton, CJ
      Combined adenovirus-mediated nitroreductase gene delivery and CB1954 treatment: A well-tolerated therapy for established solid tumors

      MOLECULAR THERAPY
    2. Damen, EWP; de Groot, FMH; Scheeren, HW
      Novel anthracycline prodrugs

      EXPERT OPINION ON THERAPEUTIC PATENTS
    3. Heine, D; Muller, R; Brusselbach, S
      Cell surface display of a lysosomal enzyme for extracellular gene-directedenzyme prodrug therapy

      GENE THERAPY
    4. Plumb, JA; Bilsland, A; Kakani, R; Zhao, JQ; Glasspool, RM; Knox, RJ; Evans, TRJ; Keith, WN
      Telomerase-specific suicide gene therapy vectors expressing bacterial nitroreductase sensitize human cancer cells to the pro-drug CB1954

      ONCOGENE
    5. Kan, O; Griffiths, L; Baban, D; Iqball, S; Uden, M; Spearman, H; Slingsby, J; Price, T; Esapa, M; Kingsman, S; Kingsman, A; Slade, A; Naylor, S
      Direct retroviral delivery of human cytochrome P4502B6 for gene-directed enzyme prodrug therapy of cancer

      CANCER GENE THERAPY
    6. Denny, WA
      Prodrug strategies in cancer therapy

      EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
    7. Folkes, LK; Wardman, P
      Oxidative activation of indole-3-acetic acids to cytotoxic species - a potential new role for plant auxins in cancer therapy

      BIOCHEMICAL PHARMACOLOGY
    8. Burke, PJ
      The potential use of carboxypeptidase G(2) in the treatment of cancer

      EXPERT OPINION ON THERAPEUTIC PATENTS
    9. Weyel, D; Sedlacek, HH; Muller, R; Brusselbach, S
      Secreted human beta-glucuronidase: a novel tool for gene-directed enzyme prodrug therapy

      GENE THERAPY
    10. Greco, O; Patterson, AV; Dachs, GU
      Can gene therapy overcome the problem of hypoxia in radiotherapy?

      JOURNAL OF RADIATION RESEARCH
    11. Jaffar, M; Stratford, IJ
      Bioreductive drugs: selectivity towards hypoxic tissue

      EXPERT OPINION ON THERAPEUTIC PATENTS
    12. Fonseca, MJ; Storm, G; Hennink, WE; Gerritsen, WR; Haisma, HJ
      Cationic polymeric gene delivery of beta-glucuronidase for doxorubicin prodrug therapy

      JOURNAL OF GENE MEDICINE
    13. Bakina, E; Farquhar, D
      Intensely cytotoxic anthracycline prodrugs: galactosides

      ANTI-CANCER DRUG DESIGN
    14. Niculescu-Duvaz, I; Friedlos, F; Niculescu-Duvaz, D; Davies, L; Springer, CJ
      Prodrugs for antibody- and gene-directed enzyme prodrug therapies (ADEPT and GDEPT)

      ANTI-CANCER DRUG DESIGN
    15. Hmphreys, MJ; Greenhalf, W; Neoptolemos, JP; Ghaneh, P
      The potential for gene therapy in pancreatic cancer

      INTERNATIONAL JOURNAL OF PANCREATOLOGY
    16. BLAKEY D
      ENZYME PRODRUG THERAPY OF CANCER

      Expert opinion on therapeutic patents
    17. SIIM BG; DENNY WA; WILSON WR
      NITRO REDUCTION AS AN ELECTRONIC SWITCH FOR BIOREDUCTIVE DRUG ACTIVATION

      Oncology research
    18. SHERWOOD RF
      ADVANCED DRUG-DELIVERY REVIEWS - ENZYME PRODRUG THERAPY

      Advanced drug delivery reviews
    19. SPRINGER CJ; NICULESCUDUVAZ I
      GENE-DIRECTED ENZYME PRODRUG THERAPY (GDEPT) - CHOICE OF PRODRUGS

      Advanced drug delivery reviews
    20. DENNY WA; WILSON WR; HAY MP
      RECENT DEVELOPMENTS IN THE DESIGN OF BIOREDUCTIVE DRUGS

      British Journal of Cancer
    21. CONNORS TA; KNOX RJ
      PRODRUGS IN CANCER-CHEMOTHERAPY

      Stem cells
    22. BRIDGEWATER JA; SPRINGER CJ; KNOX RJ; MINTON NP; MICHAEL NP; COLLINS MK
      EXPRESSION OF THE BACTERIAL NITROREDUCTASE ENZYME IN MAMMALIAN-CELLS RENDERS THEM SELECTIVELY SENSITIVE TO KILLING BY THE PRODRUG CB1954

      European journal of cancer


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 16/01/21 alle ore 19:59:02